Axtria’s Coverage On The Impact Of COVID-19 On The Pharmaceutical & Life Sciences Industry.

COVID-19: Analyzing The Impact & Way Forward

Coronavirus

Axtria’s Coverage On The Impact Of COVID-19 On The Pharmaceutical & Life Sciences Industry.

COVID-19: Analyzing The Impact & Way Forward
Drug Pricing Policies Under The Biden Administration

Blog

Drug Pricing Policies Under The Biden Administration
Do Pharma Companies Need To Rethink Their Sales Operations Design?

White Paper

Do Pharma Companies Need To Rethink Their Sales Operations Design?

Blog

Continued Need For Pharmaceutical Economic Analysis Of COVID-19 Induced Effects On Drug Demand

Blog

Long-Term Changes Brought on by COVID-19 to the Pharma Industry

Blog

Long-Term Economic Challenges Facing The US Pharma Industry
COVID-19 Recession V/s The Great Recession

White Paper

Why The COVID-19 Recession Is Different And More Dangerous Than The Great Recession
Forecasting And Analytics Techniques for Pharma Companies

White Paper

What Analytical Techniques Should Pharma Companies Implement To Estimate And Forecast COVID-19 Effects?
Long-Term Health Consequences of the COVID-19 Induced Recession

Blog

Choosing Between Food and Medicine: Long-Term Health Consequences of the COVID-19 Induced Recession
Upcoming Pharma US elections 2020

White Paper

What Is At Stake For The Pharma Industry From The Upcoming 2020 Elections: How Should Companies Prepare?
Are Pharma companies prepared to improve commercial analytics

Blog

Are Pharma Companies Prepared to Improve Dramatically How Economic Dynamics are Incorporated into Commercial Analytics?
Drug Price Control

Blog

How Should Pharma Companies Prepare for Future Price Controls?
COVID-19 Immune Incentive Compensation

Case Study

Creating A COVID-19 Immune Incentive Compensation Plan
Accordian Effect

Blog

More Evidence of a COVID-19 Induced Accordion Recession Cycle Effect
Pharma Commercial Models

Blog

Impact of COVID-19 on the Commercial Models of Pharmaceutical Companies in the US
White Paper - COVID -19 Pharma Industry Impact

White Paper

Will The Pharma Industry’s Response To COVID-19 Positively Affect Its Image? A Commentary
Omnichannel Engagement

Webinar

Is COVID-19 Accelerating The Pharma Industry’s Journey Toward Omnichannel Customer Engagement?
Effects of a resurgence in COVID-19 cases on future pharma business planning

White Paper

Effects Of A Resurgence In COVID-19 Cases On Future Pharmaceutical Business Planning
Brand Forecasting

Blog

How Will The Accordion Effect Impact Your Brand Performance In Q4-2020 And Q1-2021?
COVID-19 Recession Effects on Pharmaceutical Patient Health Outcomes

White Paper

COVID-19 Recession Effects On Pharmaceutical-Related Patient Health Outcomes
Webinar

Webinar

PMSA Webinar: A Strategic View Of The Economic Effects Of COVID-19
Shattering Sales and Marketing Silos

Blog

Will the Coronavirus Pandemic Force the Life Sciences Industry to Shatter the Sales and Marketing Silos?
Roadmap for Omnichannel Marketing

Blog

A Roadmap for Establishing and Maturing Omnichannel Marketing Within Life Sciences
Coronavirus Pandemic Effects On Incentive Compensation

White Paper

Coronavirus Pandemic Effects On Incentive Compensation
Incentive Compensation Webinar

Webinar

PMSA Webinar: Managing Incentive Compensation During COVID-19
Jassi's Message on COVID-19 preparedness

CEO Message

COVID-19 Preparedness – A Message from Jassi Chadha
COVID-19 Impact on US Pharma

White Paper

How Will The Coronavirus Pandemic Affect The US Pharmaceutical Industry?
US Pharma Supply Chain

Blog

How the Coronavirus is Causing Havoc in the US Pharma Supply Chain
Coronavirus - Global Impact

White Paper

Can The Coronavirus Contagion Economically Infect The Global Pharmaceutical Industry?
COVID-19

Blog

COVID-19: AI and Big Data for Treatment, Containment, and Flattening the Curve

Let us help your business today.
Start your journey now.

CONTACT US

Start typing and press Enter to search